AbbVie Inc. (NASDAQ:ABBV) declared a quarterly dividend on Friday, September 19th. Stockholders of record on Wednesday, October 15th will be given a dividend of 0.42 per share on Monday, November 17th. This represents a $1.68 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Friday, October 10th. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 21.70% and weekly performance is 0.09%. On last trading day company shares ended up $56.72. AbbVie Inc. (NYSE:ABBV) distance from 50-day simple moving average (SMA50) is 1.32%.

Alcatel-Lucent (NYSE:ALU) has today opened an innovative facility in Tokyo designed to give service providers and enterprise customers hands-on experience in the co-creation of new ultra-broadband and cloud-based services and applications. The Alcatel-Lucent Customer Network Center (CNC) is a first-of-its-kind in Japan – one of the world’s most advanced telecommunications markets – and has been created to make networking trends, most notably the trend towards cloud-based networking, tangible for customers. In the CNC, Alcatel-Lucent customers can participate in interactive demonstrations and co-creation opportunities that lead to the creation of new business models. Alcatel Lucent SA (ADR) (NYSE:ALU) shares moved down -9.51% in last trading session and ended the day at $2.57. ALU Gross Margin is 33.00% and its return on assets is -2.10%. Alcatel Lucent SA (ADR) (NYSE:ALU) quarterly performance is -25.72%.

SCANA Corporation (NYSE: SCG) will release its third quarter earnings on Thursday, October 30, 2014, before the market opens. On 09 October, SCANA Corp. (NYSE:SCG) shares moved down -1.76% and was closed at $48.48. SCG EPS growth in last 5 year was 2.70%. SCANA Corp. (NYSE:SCG) year to date (YTD) performance is 6.55%.

Amicus Therapeutics (NASDAQ:FOLD) CFO William D. Baird III sold 10,000 shares of the stock on the open market in a transaction dated Friday, October 3rd. The shares were sold at an average price of $7.00, for a total value of $70,000.00. Following the completion of the transaction, the chief financial officer now directly owns 100,000 shares in the company, valued at approximately $700,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) ended the last trading day at $6.36. Company weekly volatility is calculated as 7.77% and price to cash ratio as 6.42. Amicus Therapeutics, Inc. (NASDAQ:FOLD) showed a weekly performance of -3.05%.

AutoZone Inc. (NYSE:AZO) has been given a “BBB” credit rating by Morningstar. The investment research firm’s “BBB” rating suggests that the company is a moderate default risk. They also gave their stock a three star rating. AutoZone, Inc. (NYSE:AZO) shares moved down -1.83% in last trading session and ended the day at $508.32. AZO Gross Margin is 52.10% and its return on assets is 20.70%. AutoZone, Inc. (NYSE:AZO) quarterly performance is -4.71%.